Bioscript Group

At Bioscript Group, we're driven by the expertise and passion of our talented individuals. Today, we shine the spotlight on @Rebecca Jessop, one of Bioscript Group's Principal Regulatory Writers ✍️ Becky plays a pivotal role in: 📝 Authoring and coordinating the development of critical regulatory documents, ensuring scientific accuracy and clarity. 🔍 Translating complex data into compelling narratives that support successful drug approvals. Connect with Becky on LinkedIn and learn more about her Regulatory Writing expertise below! 👇 #RegulatoryWriting #MedComms #BioscriptGroup

The importance of real-world evidence (RWE) and patient-reported outcomes (PROs) cannot be understated in demonstrating the true value of new therapies. HTA bodies, such as NICE in the UK, increasingly demand this type of evidence, recognising that clinical trial data is not the full story. At Bioscript Group, we understand that successful market access requires a proactive, collaborative approach that integrates RWE and PROs into your strategy from the earliest stages of development. 🤝Early engagement is key: By involving market access experts alongside medical affairs from the outset, we can ensure that your clinical trials are designed to generate the evidence payers need to make informed decisions. 📊Data-driven insights: Our team of senior scientists leverages RWE and PROs to build a compelling, patient-centric case for your therapy, showcasing its real-world effectiveness and value. 🗣️Strategic storytelling: We translate complex data into clear, impactful narratives that resonate with payers and HTA bodies. We're not just a service provider; we're your strategic partner in ensuring your innovative therapies reach those who need them most #MarketAccess #HealthcareCommunications #Pharma Valid Insight (part of the Bioscript Group)

With advances in technology and improving standards of care, market differentiation and blockbuster status are becoming increasingly more challenging to achieve. Bioscript Group's strategic planning services are designed to guide you through this new reality. We blend scientific expertise with data-driven insights to craft compelling narratives that resonate with key stakeholders and drive commercial success. Why you should partner with us: 🎓 15 years' experience navigating the complex healthcare landscape. 💡 Our embedded insight engine empowers evidence-based decision-making at every stage. 📊 We blend science, data, and creativity to deliver the most compelling science to the right stakeholder at the right time. Together, let's create impactful strategies that achieve your commercial goals in the era of precision medicine. #MedComms #HealthcareCommunication #Pharma #MarketAccess #bioscriptgroup

Cell and gene therapies (CGTs) offer incredible potential, but accessing these revolutionary treatments faces unique hurdles: 📊Limited data, long-term value: Demonstrating the lasting impact of CGTs with limited clinical trial follow-up requires innovative approaches to value assessment. 🧠Rethinking value frameworks: Traditional health economic models may not capture the full value of CGTs. We need new frameworks that reflect their unique cost-benefit profile and potential for cure. 💰Beyond upfront costs: High initial costs demand innovative payment models. Exploring options like outcomes-based agreements is crucial to ensure affordability and patient access. Navigating this complex landscape requires expertise and strategic thinking. At Valid Insight (part of the Bioscript Group) we help CGT developers demonstrate value, optimise pricing and secure market access. Contact us today to learn how we can help you bring these breakthrough therapies to patients. 👇 https://loom.ly/FgfOZeE #CellAndGeneTherapy #MarketAccess #Pharma #bioscriptgroup

🌍 Join us at the World Orphan Drug Congress 2024! 🌍 We’re excited to announce that Gerdi Strydom, Stephen H., Sarah Holland, and Inês Rodrigues de Oliveira will be representing Valid Insight (part of the Bioscript Group) at the World Orphan Drug Congress in Barcelona, 22-25 October. Come visit us at Booth 111 or schedule a meeting in advance by contacting us at discover@bioscriptgroup.com. Let’s discuss how we can help you navigate the challenges of market access, rare diseases, and orphan drugs. #WorldOrphanDrugCongress, #OrphanDrugs, #RareDisease, #PatientAdvocacy, #MarketAccess

We are thrilled to share that our Managing Director, Gerdi Strydom, was a special guest on the Market Access Podcast (MAP) hosted by Stefan Dr. Walzer from MArS Market Access & Pricing Strategy GmbH. 🎙️ In this insightful episode, Gerdi dives into the growing importance of integrating #ESG (Environmental, Social, and Governance) principles into #HealthTechnologyAssessments (HTAs) and discusses how sustainability is reshaping healthcare, industry strategy, and payor decision-making across Europe. 🌿 Tune in to hear about: 🔹 The role of carbon footprint and environmental impact in shaping policy and healthcare decision-making. 🔹 How some are leading the way with low-carbon pharmaceuticals, including healthcare systems and the pharmaceutical industry. 🔹 The future of market access and how global collaboration drives healthcare sustainability. 🎧 Listen to the full episode here: https://lnkd.in/dyTZ3yQb Join the conversation and stay ahead of the trends in market access and sustainability! #HealthcareInnovation #Sustainability #HTA #ESG #MarketAccess

With new insights, shifting trends, and evolving stakeholder perspectives—the narrative in medical research never stands still. At Bioscript Group, we empower you to navigate this dynamic landscape with Bioscript Data Insights (BDI). BDI isn't just data, it's a strategic advantage, going beyond basic metrics with advanced analytics capabilities that help you transform your vast datasets into actionable strategic knowledge. With BDI, you can: 🗣️ Analyse language and sentiment to truly understand your audience. 💬 Monitor online conversations to pinpoint key influencers. 📊 Track evidence and trends to ensure your communication stays ahead of the curve. The result? Proactive and tailored narratives that resonate, anticipate challenges and drive real-world impact. Ready to elevate your medical communication? Discover BDI's transformative power. 👇 https://loom.ly/xvUob3Y #MarketAccess #MedComms #DataAndInsights #bioscriptgroup

At Bioscript Group, we believe that a healthy and supportive work environment is crucial for both individual success and collective excellence. Earlier this year we were joined by wellbeing consultant Michelle Langer for an interactive workshop on "Moving More for Mental Health: Optimising Your Workspace for Focus and Productivity." Here are some top tips from Michelle about maintaining focus and well-being in the workplace: 🎯 Focus on a single task at a time where possible 🚶♀️ Take a screen and movement break at least once an hour 📱 Schedule social media and news checks at a specific time 🧠 Incorporate dedicated focus time in the morning 💬Tell others when you need to focus 🔕 Turn off unnecessary pop-up distractions, especially during meetings This #MentalHealthAwarenessDay, let's commit to creating a workplace where mental health is prioritised and everyone feels empowered to reach their full potential. 💚 Feel free to share your own tips below! #MentalHealthMatters #MedComms #MarketAccess #MentalHealthAwarenessDay #bioscriptgroup

Are your medical communications missing the mark? The solution could be simpler than you think: embrace the art of data-powered storytelling. Storytelling is not merely a creative flourish; it is deeply rooted in human psychology. Narratives tap into our emotions, forging connections that make information understandable, memorable, and compelling. This data-driven approach empowers us to craft compelling, evidence-based stories that: 🤝Builds trust 💡Increase understanding 📢Resonate with audiences 💪Inspire action Discover the science behind data-driven storytelling and its pivotal role in cutting through the noise in our latest article in pharmaphorum by Adam Goodband, Co-founder and Science Communication Director at Enzyme Communications (part of the Bioscript Group) 👇 https://loom.ly/GdEuVac #Pharma #DataAndInsights #MedComms #MarketAccess #bioscriptgroup

🎗️ October marks Breast Cancer Awareness Month 🎗️ The devastating reality: 1,000 lives are lost to secondary breast cancer each month in the UK. While advancements in targeted therapies and immunotherapy offer hope, not everyone has equal access to these breakthroughs. True progress in breast cancer care goes beyond awareness. We must focus on health equity, ensuring everyone has access to the latest advancements, regardless of their background or location. This #BreastCancerAwarenessMonth, we advocate for a multi-faceted approach to tackling this complex challenge: 🤝Collaboration between governments, public health bodies, and communities is essential for promoting prevention strategies and improving early detection rates, especially in underserved populations. 🧪 Academia and pharma must continue to push the boundaries of research, developing more targeted diagnostics and treatments that address health disparities and improve outcomes for all. 🔬 Prioritisation of diversity in clinical trials to ensure new treatments are effective for all patients, regardless of their socioeconomic background. 🗣️ Clear, accessible communication to address health disparities, empower patients and break down barriers to information and care. Let's work together to build a more equitable and hopeful future for those affected by breast cancer. #HealthEquity #MarketAccess #Oncology #BioscriptGroup